1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Dual SGLT1/SGLT2 inhibitor phlorizin reduces glucose transport in experimental peritoneal dialysis
(
- Contribution to journal › Article
- 2022
-
Mark
Optimised versus standard automated peritoneal dialysis regimens pilot study (OptiStAR) : A randomised controlled crossover trial
(
- Contribution to journal › Article
- 2021
-
Mark
SGLT2 inhibition does not reduce glucose absorption during experimental peritoneal dialysis
(
- Contribution to journal › Article
- 2020
-
Mark
Optimized vs. Standard Automated Peritoneal Dialysis Regimens (OptiStAR) : Study protocol for a randomized controlled crossover trial
(
- Contribution to journal › Article